Beta Bionics Inc
Veridion Score
Composite trend over time
Why is BBNX moving today?
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Warehouse intelligence for BBNX.
BBNX insider activity
Beta Bionics Inc
No multi-insider buying cluster in the last 90 days
Net selling: -$3.3M across loaded Form 4 rows.
Loaded official disclosures do not show all three sources aligned on this ticker.
| Filing date | Trade date | Insider | Title | Type | Price | Qty | Owned | Value | Receipt |
|---|---|---|---|---|---|---|---|---|---|
| 2026-07-02 | 2026-06-29 | Feider Stephen | Insider | sell | $17.03 | 4,896 | 166,053 | $83K | SEC Form 4 |
| 2026-07-02 | 2026-06-29 | Feider Stephen | Insider | buy | $5.10 | 4,896 | 170,949 | $25K | SEC Form 4 |
| 2026-07-02 | 2026-06-26 | Feider Stephen | Insider | sell | $17.05 | 5,104 | 166,053 | $87K | SEC Form 4 |
| 2026-07-02 | 2026-06-26 | Feider Stephen | Insider | buy | $5.10 | 5,104 | 171,157 | $26K | SEC Form 4 |
| 2026-06-25 | 2026-06-24 | Hopman Mark | Insider | sell | $15.01 | 1,258 | 129,354 | $19K | SEC Form 4 |
Showing 5 recent rows. Sovereign unlocks 62 additional rows, full sorting, and the named-filer history.
Upgrade to Sovereign · $25/moBBNX contract awards, year to date.
Public federal awards linked to this ticker.
BBNX lobbying filings, year to date.
Registered lobbying filings matched to Beta Bionics Inc.